Study List: Study 1: Title: Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations Status: Recruiting Study Results: No Results Available Conditions: Marijuana Impairment Interventions: Drug: Low Dose THC Marijuana|Drug: High Dose THC Marijuana|Drug: Placebo Marijuana Locations: Olin Neuropsychiatry Research Center, Hartford, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03191084 Study 2: Title: Neuroscience of Marijuana Impaired Driving Status: Recruiting Study Results: No Results Available Conditions: Marijuana Impairment Interventions: Drug: Low dose THC marijuana|Drug: High dose THC marijuana|Drug: Placebo marijuana Locations: Olin Neuropsychiatry Research Center, Hartford, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02757313 Study 3: Title: Neuroscience of Alcohol and Marijuana Impaired Driving Status: Recruiting Study Results: No Results Available Conditions: Marijuana Usage|Alcohol Drinking Interventions: Drug: One day with a dose of placebo cannabis paired with alcohol|Drug: One day with a dose of active THC cannabis paired with alcohol Locations: Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03431987 Study 4: Title: Marijuana Treatment Project 4 Status: Active, not recruiting Study Results: No Results Available Conditions: Marijuana Dependence Interventions: Behavioral: Contingency Management|Behavioral: Individualized Assessment & Treatment|Behavioral: Cognitive-Behavioral Treatment Locations: University of Connecticut Health Center, Farmington, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02030665 Study 5: Title: Marijuana in Combination With Opioids in Palliative and Hospice Patients Status: Enrolling by invitation Study Results: No Results Available Conditions: Pain Management in Terminally Ill Patients Receiving Scheduled Opioid Therapy Interventions: Drug: Medical Marijuana Locations: The Connecticut Hospice Inc., Branford, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03233633 Study 6: Title: Marijuana Treatment Project - 3 Status: Completed Study Results: No Results Available Conditions: Marijuana Dependence Interventions: Behavioral: Reinforcement for homework completion|Behavioral: Reinforcement for Abstinence|Behavioral: Case Management Locations: University of Connecticut Health Center, Farmington, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00107588 Study 7: Title: Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1 Status: Completed Study Results: No Results Available Conditions: Marijuana Abuse Interventions: Drug: Selegiline hydrochloride|Drug: Placebo Locations: MRU, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00218517 Study 8: Title: The Neural Correlates of Cannabis Use Status: Recruiting Study Results: No Results Available Conditions: Cannabis Dependence|Healthy Interventions: Other: [11-C]OMAR Locations: Conneticut Mental Health Center, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03104257 Study 9: Title: Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use Status: Completed Study Results: No Results Available Conditions: Alcohol Drinking|Marijuana Interventions: Behavioral: Text Messaging and Brief Negotiation Interview Locations: Yale New Haven Hospital, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03401333 Study 10: Title: Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal Status: Active, not recruiting Study Results: No Results Available Conditions: Cannabis Dependence Interventions: Drug: PF-04457845|Drug: Placebo Locations: Yale University School of Medicine, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01618656 Study 11: Title: Galantamine Effects on Cognitive Function in Marijuana Users Status: Completed Study Results: No Results Available Conditions: Memory Interventions: Drug: Placebo|Drug: Galantamine Locations: Department of Veterans Affairs, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00969696 Study 12: Title: Adaptive Treatment for Adolescent Cannabis Use Disorders Status: Completed Study Results: No Results Available Conditions: Mental Disorders|Addictive Behaviors|Cannabis Use Disorder Interventions: Behavioral: ACRA|Behavioral: CBT Locations: University of Connecticut Health Center, Farmington, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01656707 Study 13: Title: Imaging the Neurochemistry of Drug Addiction With PET Status: Recruiting Study Results: No Results Available Conditions: Smoking|Cannabis Interventions: Drug: cannabis Locations: Connecticut Mental Health Center, New Haven, Connecticut, United States|Yale Magnetic Resonance Research Center, New Haven, Connecticut, United States|Yale PET Center, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02817698 Study 14: Title: Dronabinol Interactions With Cognitive Enhancing Drug in Humans Status: Completed Study Results: Has Results Conditions: Cannabis|Marijuana Abuse Interventions: Drug: drug condition Locations: Department of Veterans Affairs Hospital, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00842985 Study 15: Title: Pharmacogenetics of Cannabinoid Response Status: Active, not recruiting Study Results: No Results Available Conditions: COMT Gene Polymorphism Interventions: Drug: delta 9 tetrahydrocannabinol Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00678730 Study 16: Title: Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management Status: Completed Study Results: No Results Available Conditions: Marijuana Dependence Interventions: Behavioral: Standard CBT|Behavioral: CBT+CM/adherence|Behavioral: CM/abstinence|Behavioral: CM/abstinence+CBT Locations: ASAP/1 Long Wharf, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00350649 Study 17: Title: Cannabinoids, Neural Synchrony, and Information Processing Status: Active, not recruiting Study Results: No Results Available Conditions: Cannabis|Psychotic Disorders Interventions: Drug: THC|Drug: Placebo Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00708994 Study 18: Title: Development of a Videogame Prototype Targeting Cigarette and Marijuana Smoking, and Tobacco Product Prevention Among Young Adolescents (smokeScreen) Status: Completed Study Results: No Results Available Conditions: Smoking Interventions: Device: smokeSCREEN video game Locations: Hamden Youth Center, Hamden, Connecticut, United States|Leadership, Education, and Athletics Partnership (LEAP) Inc., New Haven, Connecticut, United States|Farnam Neighborhood House, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03722888 Study 19: Title: Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning Status: Recruiting Study Results: No Results Available Conditions: Schizophrenia|Cannabis Dependence|Prodromal for Psychotic Illness|Family History of Alcoholism|Healthy Control Interventions: Radiation: [11-C]OMAR Locations: Connecticut Mental Health Center, Clinical Neuroscience Research Unit, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01730781 Study 20: Title: The Effects of ∆-9-THC and Naloxone in Humans Status: Active, not recruiting Study Results: No Results Available Conditions: Healthy Interventions: Drug: Naloxone|Drug: Delta-9-THC|Drug: Placebo Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01591629 Study 21: Title: Therapeutic Substance Abuse Treatment in Pregnancy - 1 Status: Completed Study Results: Has Results Conditions: Alcohol Abuse|Cocaine Abuse|Marijuana Abuse Interventions: Behavioral: MI-CBT|Behavioral: Brief Advice Locations: Bridgeport Hospital, Bridgeport, Connecticut, United States|Yale-New Haven Hospital, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00227903 Study 22: Title: Cannabinoids and Cerebellar-Motor Functioning Status: Unknown status Study Results: No Results Available Conditions: Cannabis|Psychotic Disorders Interventions: Drug: THC|Drug: Placebo Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01853020 Study 23: Title: Effects of Delta-9-THC and Iomazenil in Healthy Humans Status: Active, not recruiting Study Results: No Results Available Conditions: Schizophrenia|Mental Disorders|Psychotic Disorders Interventions: Drug: THC and Iomazenil|Drug: Placebo (control) Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00982982 Study 24: Title: Development of a Videogame Prototype Targeting Cigarette and Marijuana Smoking, and Tobacco Product Prevention Among Young Adolescents Status: Completed Study Results: No Results Available Conditions: Smoking Interventions: Behavioral: smokeSCREEN game Locations: Hamden Youth Center, Hamden, Connecticut, United States|Leadership, Education, and Athletics Partnership (LEAP) Inc., New Haven, Connecticut, United States|Yale New Haven Hospital, New Haven, Connecticut, United States|Farnam Neighborhood House, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03107936 Study 25: Title: Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II Status: Active, not recruiting Study Results: No Results Available Conditions: Cannabis|Alcohol Effect|Driving Under the Influence of Alcohol and Other Drugs Interventions: Drug: Active inhaled cannabis|Drug: Placebo|Drug: Active Oral Ethanol Locations: Biological Studies Unit, VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02710097 Study 26: Title: Treatment for Teens With Alcohol Abuse and Depression Status: Active, not recruiting Study Results: No Results Available Conditions: AOD Use, Abuse, and Dependence|Depression Interventions: Behavioral: MET/CBT-12|Behavioral: CBT-D|Other: D-TAU Locations: University of Connecticut Health Center, Farmington, Connecticut, United States|Duke Child and Family Study Center, Durham, North Carolina, United States URL: https://ClinicalTrials.gov/show/NCT02227589 Study 27: Title: The Effects of Cannabidiol and ∆-9-THC in Humans Status: Active, not recruiting Study Results: No Results Available Conditions: Healthy Interventions: Drug: Cannabidiol|Drug: Delta-9-THC|Drug: Placebo Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01180374 Study 28: Title: Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I Status: Recruiting Study Results: No Results Available Conditions: Cannabis Interventions: Drug: Placebo|Drug: Dronabinol Locations: Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02811510 Study 29: Title: Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans Status: Recruiting Study Results: No Results Available Conditions: Cannabis Interventions: Drug: THC|Drug: Placebo Locations: Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02781519 Study 30: Title: Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I Status: Recruiting Study Results: No Results Available Conditions: Cannabis|Alcohol Effect|Driving Under the Influence of Alcohol and Other Drugs Interventions: Drug: Active inhaled delta-9-THC|Drug: Placebo|Drug: Active Oral Ethanol Locations: Biological Studies Unit, VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02709954 Study 31: Title: Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition Status: Recruiting Study Results: No Results Available Conditions: Cannabis|Alcohol Effect|Driving Under the Influence of Alcohol and Other Drugs Interventions: Drug: Active delta-9-THC|Drug: Placebo|Drug: Active Ethanol Locations: Biological Studies Unit, VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02404688 Study 32: Title: Cannabinoids, Learning, and Memory Status: Recruiting Study Results: No Results Available Conditions: Cannabis|Psychotic Disorders Interventions: Drug: THC|Drug: Placebo Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02407808 Study 33: Title: Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III Status: Recruiting Study Results: No Results Available Conditions: Cannabis|Alcohol Effect|Driving Under the Influence of Alcohol and Other Drugs Interventions: Drug: Active Dronabinol|Drug: Placebo|Drug: Active Ethanol Locations: Biological Studies Unit, VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02710331 Study 34: Title: Probing the Cannabinoid System in Individuals With a Family History of Psychosis Status: Recruiting Study Results: No Results Available Conditions: Psychosis|Cannabis Use|THC|Marijuana|Schizophrenia Interventions: Drug: Placebo|Drug: Very Low Dose THC|Drug: Low Dose THC Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02102113 Study 35: Title: Cannabinoid Receptor Function & Alcoholism Status: Active, not recruiting Study Results: No Results Available Conditions: Alcoholism Interventions: Drug: THC|Drug: Placebo Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00624715 Study 36: Title: Screening to Augment Referral to Treatment- Project START Status: Completed Study Results: Has Results Conditions: Alcohol Abuse|Tobacco Use Disorder|Marijuana Abuse|Substance-Related Disorders Interventions: Behavioral: Motivational Interview|Other: Treatment as Usual Locations: Yale-New Haven Hospital- York St Campus, New Haven, Connecticut, United States|Yale-New Haven Hospital-Chapel St Campus, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01539525 Study 37: Title: Contingency Management for Smoking in Substance Abusers Status: Completed Study Results: No Results Available Conditions: Cigarette Smoking Interventions: Behavioral: Contingency Management|Behavioral: Brief smoking cessation counseling Locations: University of Connecticut Health Center, Farmington, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00683033 Study 38: Title: Healthy Activities for Prize Incentives Status: Completed Study Results: No Results Available Conditions: Substance Abuse|HIV Infections Interventions: Behavioral: contingency management Locations: Connections, Inc., Hartford, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00717444 Study 39: Title: CB1R in Synthetic Psychoactive Cannabinoids Status: Recruiting Study Results: No Results Available Conditions: Drug Dependence Interventions: Other: [11-C]OMAR Locations: Connecticut Mental Health Center, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03539575 Study 40: Title: Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder Status: Active, not recruiting Study Results: No Results Available Conditions: Delta-9-Tetrahydroncannabinol|Bipolar Disorder|Healthy Controls Interventions: Drug: 4 mg Delta-9-THC|Drug: Placebo|Drug: 2 mg Delta-9-THC Locations: Biological Studies Unit, VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03206463 Study 41: Title: N-acetylcysteine Effects on Tetrahydrocannabinol Status: Active, not recruiting Study Results: No Results Available Conditions: Healthy Interventions: Drug: Delta-9-THC|Drug: N-acetylcysteine|Drug: Placebo Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02335060 Study 42: Title: Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment Status: Completed Study Results: Has Results Conditions: Cannabis Dependence Interventions: Drug: N-Acetylcysteine|Drug: Placebo Locations: UCLA Integrated Substance Abuse Programs, Los Angeles, California, United States|APT Foundation, Inc., New Haven, Connecticut, United States|University of Kentucky, Lexington, Kentucky, United States|CODA, Inc., Portland, Oregon, United States|Behavioral Health Services of Pickens County, Pickens, South Carolina, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States URL: https://ClinicalTrials.gov/show/NCT01675661 Study 43: Title: Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone Status: Recruiting Study Results: No Results Available Conditions: Healthy Interventions: Drug: Active Delta-9-THC|Drug: Active Pregnenolone|Drug: Placebo Locations: Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02576912 Study 44: Title: Cannabidiol Treatment in Patients With Early Psychosis Status: Active, not recruiting Study Results: No Results Available Conditions: Schizophrenia|Schizoaffective Disorder Interventions: Drug: Cannabidiol|Drug: Placebo Locations: Connecticut Mental Health Center, New Haven, Connecticut, United States|VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02504151 Study 45: Title: Cannabinoid Modulation of Pain Status: Active, not recruiting Study Results: No Results Available Conditions: Pain Interventions: Other: Thermal|Device: Electrical|Other: Capsaicin Locations: VA Connecticut Healthcare System, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01595620 Study 46: Title: Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I Status: Recruiting Study Results: No Results Available Conditions: Healthy Interventions: Drug: Active Dronabinol|Drug: Active Pregnenolone|Drug: Placebo Dronabinol|Drug: Placebo Pregnenolone Locations: Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02811939 Study 47: Title: A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence Status: Completed Study Results: No Results Available Conditions: Opioid Dependence Interventions: Other: Naturalistic Prospective Cohort Locations: APT Foundation, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT02718352 Study 48: Title: An Interactive Game for HIV Prevention in Early Adolescents Status: Completed Study Results: No Results Available Conditions: HIV|Risk Reduction Interventions: Behavioral: Experimental Video Game|Behavioral: Off the Shelf Video Game Locations: Yale School of Medicine, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01666496 Study 49: Title: Stage I Randomized Trial of Mentalization-Based Therapy for Substance Using Mothers of Infants and Toddlers Status: Completed Study Results: Has Results Conditions: Maternal Substance Use|Child Abuse and Neglect Interventions: Behavioral: Mentalizing Therapy for Substance Using Mothers|Behavioral: Standard Parent Education for Substance Using Mothers Locations: The APT Foundation, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT00319436 Study 50: Title: Secondary HIV Prevention and Adherence Among HIV-infected Drug Users Status: Completed Study Results: No Results Available Conditions: Risk Behavior|Medication Adherence|HIV Interventions: Behavioral: 3H+ (Holistic Health for HIV)|Behavioral: HHRP+ (Holistic Health Recovery Program) Locations: APT Foundation, New Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT01741311 Study 51: Title: Study of of APL-2 Therapy in Patients Geographic Atrophy Status: Completed Study Results: No Results Available Conditions: Geographic Atrophy Interventions: Drug: APL-2|Other: Sham Procedure Locations: Retinal Research Institute, Phoenix, Arizona, United States|Retina Vitreous Asociates Mdical Goup, Beverly Hills, California, United States|The Gavin Herbert Eye Institute/UC Irvine, Irvine, California, United States|Byers Eye Institute at Standford, Stanford School of Medicine, Palo Alto, California, United States|New England Retina Associates, New London, Connecticut, United States|Florida Eye Microsurgical Institute, Inc., Boynton Beach, Florida, United States|Retina Health Center, Fort Myers, Florida, United States|Bascom Palmer Eye Institute, Miami, Florida, United States|South East Retina, Augusta, Georgia, United States|Midwest Eye Institute, Indianapolis, Indiana, United States|Ophthalmic Consultants of Boston, Boston, Massachusetts, United States|Associated Retinal Consultants PC, Grand Rapids, Michigan, United States|Associated Retinal Consultants, PC, Traverse City, Michigan, United States|Eyesight Opthalmic Services PA, Portsmouth, New Hampshire, United States|Vitreous Retina Macula Consultants of New York, New York, New York, United States|Charlotte Eye Ear Nose and Throat Associates, Charlotte, North Carolina, United States|Duke University, Duke Eye Center, Durham, North Carolina, United States|Retina Associates of Cleveland, Cleveland, Ohio, United States|Cleveland Clinica Foundation/ Cole Eye Institute, Cleveland, Ohio, United States|Tennessee Retina, PC, Nashville, Tennessee, United States|Retina Research Institute of Texas, Abilene, Texas, United States|Retina Research Center, Austin, Texas, United States|Retina Consultants of Houston, Houston, Texas, United States|Valley Retina Institute, PA, McAllen, Texas, United States|Retina Consultants of Houston (The Woodlands), The Woodlands, Texas, United States|Marsden Eye Specialists, Paramatta, New South Wales, Australia|Save Sight Institute, Sydney Eye Hospital, Sydney, New South Wales, Australia|Sydney Retina Clinic and Day Surgery, Sydney, New South Wales, Australia|Sydney West Retina, Westmead, New South Wales, Australia|Hobart eye Surgeons, Hobart, Tasmania, Australia|Tasmanian Eye Institute, South Launceston, Tasmania, Australia|Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia|Lions Eye Institute, Nedlands, Western Australia, Australia|Auckland Eye, Remuera, Auckland, New Zealand|Southern Eye Specialists, Merivale, Christchurch, New Zealand URL: https://ClinicalTrials.gov/show/NCT02503332 Study 52: Title: National Adaptive Trial for PTSD Related Insomnia Status: Not yet recruiting Study Results: No Results Available Conditions: Insomnia Interventions: Drug: Trazodone|Drug: Eszopiclone|Drug: Gabapentin|Other: Placebo Locations: VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut, United States URL: https://ClinicalTrials.gov/show/NCT03668041 Study 53: Title: Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease Status: Completed Study Results: Has Results Conditions: Hepatitis C, Chronic Interventions: Drug: eltrombopag|Drug: placebo Locations: GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Tucson, Arizona, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Arcadia, California, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Lynwood, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Clemente, California, United States|GSK Investigational Site, San Diego, California, United States|GSK Investigational Site, San Mateo, California, United States|GSK Investigational Site, Aurora, Colorado, United States|GSK Investigational Site, New Haven, Connecticut, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Bradenton, Florida, United States|GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Honolulu, Hawaii, United States|GSK Investigational Site, Chicago, Illinois, United States|GSK Investigational Site, Indianapolis, Indiana, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, New Orleans, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Burlington, Massachusetts, United States|GSK Investigational Site, Worcester, Massachusetts, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Jackson, Mississippi, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Lebanon, New Hampshire, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Manhasset, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Asheville, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Kinston, North Carolina, United States|GSK Investigational Site, Morganton, North Carolina, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Portland, Oregon, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Germantown, Tennessee, United States|GSK Investigational Site, Mountain Home, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Dallas, Texas, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Charlottesville, Virginia, United States|GSK Investigational Site, Richmond, Virginia, United States|GSK Investigational Site, Seattle, Washington, United States|GSK Investigational Site, Garran, Australian Capital Territory, Australia|GSK Investigational Site, Camperdown, New South Wales, Australia|GSK Investigational Site, Randwick, New South Wales, Australia|GSK Investigational Site, Cairns, Queensland, Australia|GSK Investigational Site, Herston, Queensland, Australia|GSK Investigational Site, Clayton, Victoria, Australia|GSK Investigational Site, Fitzroy, Victoria, Australia|GSK Investigational Site, Parkville, Victoria, Australia|GSK Investigational Site, Prahran, Victoria, Australia|GSK Investigational Site, Nedlands, Western Australia, Australia|GSK Investigational Site, Bruxelles, Belgium|GSK Investigational Site, Edegem, Belgium|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Leuven, Belgium|GSK Investigational Site, Campinas, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, Edmonton, Alberta, Canada|GSK Investigational Site, Victoria, British Columbia, Canada|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Barrie, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, London, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Hradec Kralove, Czech Republic|GSK Investigational Site, Olomouc, Czech Republic|GSK Investigational Site, Praha 6, Czech Republic|GSK Investigational Site, Cairo, Egypt|GSK Investigational Site, Mansoura, Egypt|GSK Investigational Site, Shebeen El-Kom, Menoufeya, Egypt|GSK Investigational Site, Besançon, France|GSK Investigational Site, Bondy, France|GSK Investigational Site, Dijon cedex, France|GSK Investigational Site, Grenoble, France|GSK Investigational Site, Lille, France|GSK Investigational Site, Marseille Cedex 08, France|GSK Investigational Site, Orléans, France|GSK Investigational Site, Paris Cedex 12, France|GSK Investigational Site, Paris Cedex 13, France|GSK Investigational Site, Rouen, France|GSK Investigational Site, Strasbourg, France|GSK Investigational Site, Vandoeuvre Les Nancy, France|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Mannheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, Germany|GSK Investigational Site, Deggendorf, Bayern, Germany|GSK Investigational Site, Hof/Saale, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Regensburg, Bayern, Germany|GSK Investigational Site, Wuerzburg, Bayern, Germany|GSK Investigational Site, Beeskow, Brandenburg, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Kassel, Hessen, Germany|GSK Investigational Site, Goettingen, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Rotenburg (Wuemme), Niedersachsen, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bonn, Nordrhein-Westfalen, Germany|GSK Investigational Site, Dortmund, Nordrhein-Westfalen, Germany|GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Herne, Nordrhein-Westfalen, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany|GSK Investigational Site, Leverkusen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, Germany|GSK Investigational Site, Oberhausen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Siegen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Chemnitz, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Athens, Greece|GSK Investigational Site, Athens, Greece|GSK Investigational Site, Rio, Patras, Greece|GSK Investigational Site, Thessaloniki, Greece|GSK Investigational Site, Bangalore, India|GSK Investigational Site, Chennai, India|GSK Investigational Site, Hyderabad, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Jerusalem, Israel|GSK Investigational Site, Nazareth, Israel|GSK Investigational Site, Petach Tikva, Israel|GSK Investigational Site, Rehovot, Israel|GSK Investigational Site, Safed, Israel|GSK Investigational Site, Tel Aviv, Israel|GSK Investigational Site, Catanzaro, Calabria, Italy|GSK Investigational Site, Avellino, Campania, Italy|GSK Investigational Site, Bologna, Emilia-Romagna, Italy|GSK Investigational Site, Roma, Lazio, Italy|GSK Investigational Site, Genova, Liguria, Italy|GSK Investigational Site, Brescia, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Bari, Puglia, Italy|GSK Investigational Site, San Giovanni Rotondo (FG), Puglia, Italy|GSK Investigational Site, Palermo, Sicilia, Italy|GSK Investigational Site, Busan, Korea, Republic of|GSK Investigational Site, Daegu, Korea, Republic of|GSK Investigational Site, Pusan, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Chorzow, Poland|GSK Investigational Site, Kielce, Poland|GSK Investigational Site, Raciborz, Poland|GSK Investigational Site, Szczecin, Poland|GSK Investigational Site, Warszawa, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Ponce, Puerto Rico|GSK Investigational Site, San Juan, Puerto Rico|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Constanta, Romania|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Saint-Petersburg, Russian Federation|GSK Investigational Site, Samara, Russian Federation|GSK Investigational Site, St.Peterburg, Russian Federation|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Kosice, Slovakia|GSK Investigational Site, Martin, Slovakia|GSK Investigational Site, Alicante, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, La Coruña, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Málaga, Spain|GSK Investigational Site, Palma de Mallorca, Spain|GSK Investigational Site, Pontevedra, Spain|GSK Investigational Site, Sabadell (Barcelona), Spain|GSK Investigational Site, San Sebastián, Spain|GSK Investigational Site, Sevilla, Spain|GSK Investigational Site, Valencia, Spain|GSK Investigational Site, Valencia, Spain|GSK Investigational Site, Changhua, Taiwan|GSK Investigational Site, Chia-Yi Hsien, Taiwan|GSK Investigational Site, Kaohsiung, Taiwan|GSK Investigational Site, Taichung, Taiwan|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Taiyuan Hsien, Taiwan|GSK Investigational Site, Donetsk, Ukraine|GSK Investigational Site, Kiev, Ukraine|GSK Investigational Site, Vinnitsa, Ukraine URL: https://ClinicalTrials.gov/show/NCT00529568 Study 54: Title: Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease Status: Completed Study Results: Has Results Conditions: Hepatitis C, Chronic Interventions: Drug: eltrombopag|Drug: placebo Locations: GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Tucson, Arizona, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, Los Angeles, California, United States|GSK Investigational Site, San Clemente, California, United States|GSK Investigational Site, Aurora, Colorado, United States|GSK Investigational Site, New Haven, Connecticut, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Washington, District of Columbia, United States|GSK Investigational Site, Bradenton, Florida, United States|GSK Investigational Site, Gainsville, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Orlando, Florida, United States|GSK Investigational Site, Atlanta, Georgia, United States|GSK Investigational Site, Honolulu, Hawaii, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, Burlington, Massachusetts, United States|GSK Investigational Site, Worcester, Massachusetts, United States|GSK Investigational Site, Ann Arbor, Michigan, United States|GSK Investigational Site, Detroit, Michigan, United States|GSK Investigational Site, Jackson, Mississippi, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Manhasset, New York, United States|GSK Investigational Site, New York, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Valhalla, New York, United States|GSK Investigational Site, Asheville, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Portland, Oregon, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Jackson, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Charlottesville, Virginia, United States|GSK Investigational Site, Fairfax, Virginia, United States|GSK Investigational Site, Richmond, Virginia, United States|GSK Investigational Site, Garran, Australian Capital Territory, Australia|GSK Investigational Site, Camperdown, New South Wales, Australia|GSK Investigational Site, Randwick, New South Wales, Australia|GSK Investigational Site, Fitzroy, Victoria, Australia|GSK Investigational Site, Heidelberg, Victoria, Australia|GSK Investigational Site, Melbourne, Victoria, Australia|GSK Investigational Site, Nedlands, Western Australia, Australia|GSK Investigational Site, Bruxelles, Belgium|GSK Investigational Site, Edegem, Belgium|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Leuven, Belgium|GSK Investigational Site, Campinas, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, Calgary, Alberta, Canada|GSK Investigational Site, Victoria, British Columbia, Canada|GSK Investigational Site, Winnipeg, Manitoba, Canada|GSK Investigational Site, Barrie, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Hamilton, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Toronto, Ontario, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Montreal, Quebec, Canada|GSK Investigational Site, Praha 4, Czech Republic|GSK Investigational Site, Praha 6, Czech Republic|GSK Investigational Site, Besançon, France|GSK Investigational Site, Dijon cedex, France|GSK Investigational Site, Marseille, France|GSK Investigational Site, Montpellier, France|GSK Investigational Site, Nice, France|GSK Investigational Site, Pessac Cedex, France|GSK Investigational Site, Strasbourg, France|GSK Investigational Site, Toulouse cedex 9, France|GSK Investigational Site, Toulouse, France|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Heidelberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, Germany|GSK Investigational Site, Deggendorf, Bayern, Germany|GSK Investigational Site, Hof/Saale, Bayern, Germany|GSK Investigational Site, Muenchen, Bayern, Germany|GSK Investigational Site, Regensburg, Bayern, Germany|GSK Investigational Site, Wuerzburg, Bayern, Germany|GSK Investigational Site, Beeskow, Brandenburg, Germany|GSK Investigational Site, Frankfurt, Hessen, Germany|GSK Investigational Site, Kassel, Hessen, Germany|GSK Investigational Site, Goettingen, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Hannover, Niedersachsen, Germany|GSK Investigational Site, Aachen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, Germany|GSK Investigational Site, Bonn, Nordrhein-Westfalen, Germany|GSK Investigational Site, Dortmund, Nordrhein-Westfalen, Germany|GSK Investigational Site, Duesseldorf, Nordrhein-Westfalen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Herne, Nordrhein-Westfalen, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, Germany|GSK Investigational Site, Leverkusen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Muenster, Nordrhein-Westfalen, Germany|GSK Investigational Site, Siegen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Pokfulam, Hong Kong|GSK Investigational Site, Bangalore, India|GSK Investigational Site, Chennai, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Haifa, Israel|GSK Investigational Site, Jerusalem, Israel|GSK Investigational Site, Petach Tikva, Israel|GSK Investigational Site, Safed, Israel|GSK Investigational Site, Tel Aviv, Israel|GSK Investigational Site, Catanzaro, Calabria, Italy|GSK Investigational Site, Avellino, Campania, Italy|GSK Investigational Site, Bologna, Emilia-Romagna, Italy|GSK Investigational Site, Roma, Lazio, Italy|GSK Investigational Site, Genova, Liguria, Italy|GSK Investigational Site, Brescia, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Milano, Lombardia, Italy|GSK Investigational Site, Bari, Puglia, Italy|GSK Investigational Site, San Giovanni Rotondo (FG), Puglia, Italy|GSK Investigational Site, Palermo, Sicilia, Italy|GSK Investigational Site, Busan, Korea, Republic of|GSK Investigational Site, Incheon, Korea, Republic of|GSK Investigational Site, Seoul, Korea, Republic of|GSK Investigational Site, Amsterdam, Netherlands|GSK Investigational Site, Nijmegen, Netherlands|GSK Investigational Site, Rotterdam, Netherlands|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Lahore, Pakistan|GSK Investigational Site, Bydgoszcz, Poland|GSK Investigational Site, Chorzow, Poland|GSK Investigational Site, Kielce, Poland|GSK Investigational Site, Szczecin, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Ponce, Puerto Rico|GSK Investigational Site, San Juan, Puerto Rico|GSK Investigational Site, Bucharest, Romania|GSK Investigational Site, Constanta, Romania|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Mosocow, Russian Federation|GSK Investigational Site, Smolensk, Russian Federation|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Bratislava, Slovakia|GSK Investigational Site, Kosice, Slovakia|GSK Investigational Site, Martin, Slovakia|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, Granada, Spain|GSK Investigational Site, L'Hospitalet de Llobregat. Barcelona, Spain|GSK Investigational Site, La Coruña, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, San Sebastián, Spain|GSK Investigational Site, Sevilla, Spain|GSK Investigational Site, Valencia, Spain|GSK Investigational Site, Kaohsiung, Taiwan|GSK Investigational Site, Taichung, Taiwan|GSK Investigational Site, Tainan, Taiwan|GSK Investigational Site, Taipei, Taiwan|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Bangkok, Thailand|GSK Investigational Site, Chiangmai, Thailand|GSK Investigational Site, Khon Kaen, Thailand|GSK Investigational Site, Songkla, Thailand|GSK Investigational Site, Donetsk, Ukraine|GSK Investigational Site, Kyiv, Ukraine|GSK Investigational Site, Kyiv, Ukraine|GSK Investigational Site, Vinnytsia, Ukraine|GSK Investigational Site, Glasgow, Lanarkshire, United Kingdom|GSK Investigational Site, London, United Kingdom|GSK Investigational Site, London, United Kingdom|GSK Investigational Site, Plymouth, United Kingdom URL: https://ClinicalTrials.gov/show/NCT00516321 Study 55: Title: Conversion to Embeda With Rescue Trial Status: Terminated Study Results: Has Results Conditions: Chronic Disease|Pain Interventions: Drug: morphine sulfate and naltrexone hydrochloride (EMBEDA) Locations: Adamsville Family Medicine, Adamsville, Alabama, United States|Office of David McLain, Birmingham, Alabama, United States|Monte Sano Clinical Research, LLC, Huntsville, Alabama, United States|Tennessee Valley Pain Consultants Properties, LLC, Huntsville, Alabama, United States|Sunbelt Research Group, LLC, Mobile, Alabama, United States|Office of Vaughn H. Mancha, Jr., PC, Montgomery, Alabama, United States|Dedicated Clinical Research, Goodyear, Arizona, United States|Dedicated Clinical Research, Inc, Phoenix, Arizona, United States|Redpoint Research, Phoenix, Arizona, United States|Anasazi Internal Medicine, PC, Phoenix, Arizona, United States|Cochise Clinical Research, Sierra Vista, Arizona, United States|Premiere Phamaceutical Research, LLC, Tempe, Arizona, United States|Quality of Life Medical and Research Center, LLC, Tucson, Arizona, United States|Ouachita Regional Pain Management, Hot Springs, Arkansas, United States|NEA Baptist Clinic, Jonesboro, Arkansas, United States|Hollis Family Medical Clinic, PLC, Paragould, Arkansas, United States|CSI Clinical Trials, Costa Mesa, California, United States|Global Wellness Medical Corporation, Foothill Ranch, California, United States|Chrishard Medical Group, Inglewood, California, United States|Triwest Research Associates LLC, La Mesa, California, United States|Pacific Coast Pain Management Center, Laguna Hills, California, United States|Valerius Medical Group and Research Center of Greater Long Beach, Inc., Long Beach, California, United States|LA Pain & Wellness Institute, Los Angeles, California, United States|Samaritan Center for Medical Research, Los Gatos, California, United States|Newport Beach Clinical Research Associates, Inc., Newport Beach, California, United States|Bayview Research Group, LLC, Paramount, California, United States|Pasadena Rehabilitation Institute, Pasadena, California, United States|Quality Control Research, Inc., Roseville, California, United States|Northern California Research, Sacramento, California, United States|Quality Control Research, Inc., Sacramento, California, United States|Rancho Santa Fe Medical Group, Inc., San Marcos, California, United States|Probe Clinical Research Corporation, Santa Ana, California, United States|Trinity Clinical Trials, Santa Ana, California, United States|Facility Medical Center, Upland, California, United States|Bayview Research Group, LLC, Valley Village, California, United States|Rocky Mountain Internal Medicine, PC, Aurora, Colorado, United States|Clinicos, LLC, Colorado Springs, Colorado, United States|Saint Luke's Medical Clinic, LLC, Fort Collins, Colorado, United States|ProHealth Physicians PC, Manchester, Connecticut, United States|Milford Physician Services, PC, Milford, Connecticut, United States|Orthopedic Research Institute, LLC, Boynton Beach, Florida, United States|Florida Research & Testing, LLC, Clearwater, Florida, United States|Omega Research Consultants, LLC, Debary, Florida, United States|Omega Research Consultants, LLC, DeBary, Florida, United States|West Florida Medical Associate, PA, Dunnellon, Florida, United States|International Research Associates, LLC, Hialeah, Florida, United States|Palm Springs Research Institute, Inc, Hialeah, Florida, United States|FPA Clinical Research, LLC, Kissimmee, Florida, United States|Clinical Research of Central Florida, Inc., Lakeland, Florida, United States|NextPhase Clinical Trials, Inc., Miami Beach, Florida, United States|Community Research Foundation, Inc., Miami, Florida, United States|New Horizon Research Center, Inc., Miami, Florida, United States|Harmony Clinical Research, Inc., North Miami Beach, Florida, United States|Office of Laszlo J. Mate, MD, PA, North Palm Beach, Florida, United States|Office of Richard E. Promin, MD, PA, Ocala, Florida, United States|Advent Clinical Research Centers, Inc., Pinellas Park, Florida, United States|Pain Management Strategies, Inc., Pompano Beach, Florida, United States|Sarasota Pain Medicine Research, LLC, Sarasota, Florida, United States|Stedman Clinical Trials, LLC, Tampa, Florida, United States|Clinical Research Center, LLC, Wellington, Florida, United States|Perimeter Institute for Clinical Research, Inc., Atlanta, Georgia, United States|Medical Research and Health Education Foundation, Inc., Columbus, Georgia, United States|Ialum Clinical Research, LLC, Decatur, Georgia, United States|Ialum Clinical Research, LLC, Stone Mountain, Georgia, United States|Herman Clinical Research, LLC, Suwanee, Georgia, United States|Centers for Pain Management, Tifton, Georgia, United States|Chicago Clinical Research Institute Inc., Chicago, Illinois, United States|Creve Coeur Family Practice, Creve Coeur, Illinois, United States|Office of Rebecca Knight, MD, Peoria, Illinois, United States|Josephson Wallack Munshower Neurology P.C., Indianapolis, Indiana, United States|Laporte County Institute for Clinical Research Inc., Michigan City, Indiana, United States|McKinley Research, LLC, Mishawaka, Indiana, United States|Accelovance, Inc., South Bend, Indiana, United States|Des Moines Orthopaedic Surgeons, PC, West Des Moines, Iowa, United States|The Pain Treatment Center of the Bluegrass, Lexington, Kentucky, United States|Healing Options, Louisville, Kentucky, United States|Four Rivers Clinical Research, Inc., Paducah, Kentucky, United States|Lakewood Family Practice, Russell Springs, Kentucky, United States|Diseasebusters, LLC, College Park, Maryland, United States|Office of Steven C. Miller, MD, Pikesville, Maryland, United States|Beacon Clinical Research, LLC, Brockton, Massachusetts, United States|Ronald J. Rapoport, MD, PC, Fall River, Massachusetts, United States|Boston Paincare Center, Inc., Waltham, Massachusetts, United States|Clarkston Medical Group, PC, Clarkston, Michigan, United States|Apex Medical Research, AMR, Inc., Flint, Michigan, United States|East Michigan Medical Associates, Flint, Michigan, United States|PCM Medical Services, PC, Lansing, Michigan, United States|Remedica LLC, Rochester, Michigan, United States|Michigan Lifestyle Change and Health Center, PC, Sterling, Michigan, United States|MAPS Applied Research Center, Inc., Edina, Minnesota, United States|MAPS Applied Research Center, Inc., Shakopee, Minnesota, United States|Anesthesia and Pain Control Services, Biloxi, Mississippi, United States|CRC of Jackson, LLC, Jackson, Mississippi, United States|Midsouth Anesthesia Consultants, PLLC, Southhaven, Mississippi, United States|Patterson Medical Clinic, Inc., Florissant, Missouri, United States|Quality Clinical Research Inc., Florissant, Missouri, United States|Primary Care Medicine, PC, Jefferson City, Missouri, United States|The Reiter Foundation, Inc., Anaconda, Montana, United States|Medical Pain Relief Clinic, Omaha, Nebraska, United States|Omaha Clinical Research, PC, Omaha, Nebraska, United States|Atco Medical Associates, PC, Atco, New Jersey, United States|Office of John V. Bernard, MD, Belvidere, New Jersey, United States|Central Jersey Medical Research Center, Inc., Elizabeth, New Jersey, United States|Center for Pain Management, Hackensack, New Jersey, United States|Advocare Heights Primary Care, Haddon Heights, New Jersey, United States|NJ Heart, LLC, Linden, New Jersey, United States|Spine and Pain Centers, PA, Shrewsbury, New Jersey, United States|Premier Research, Inc., Trenton, New Jersey, United States|Adirondack Medical Research Center, Glens Falls, New York, United States|Long Island Gastrointestinal Research Group LLP, Great Neck, New York, United States|Drug Trials America, Inc., Hartsdale, New York, United States|Office of Roger Kasendorf, DO, Long Beach, New York, United States|Family Health Medical Services PLLC, Mayville, New York, United States|New York Spine & Wellness Center, North Syracuse, New York, United States|North American Partners in Pain Management, LLP, Valley Stream, New York, United States|Carolina Clinical Research and Consulting, LLC, Asheboro, North Carolina, United States|Carolina Clinical Research and Consulting, LLC, Asheboro, North Carolina, United States|Joint and Muscle Research Institute, Inc., Charlotte, North Carolina, United States|Catawba Valley Internal Medicine, Hickory, North Carolina, United States|Profen Research Network at ECMA, Jacksonville, North Carolina, United States|The Center For Clinical Research, LLC, Winston-Salem, North Carolina, United States|Medical Frontiers, LLC, Carlisle, Ohio, United States|Valley Medical Research, Centerville, Ohio, United States|Hightop Medical Research Center, Cincinnati, Ohio, United States|Sentral Clinical Research Services, Cincinnati, Ohio, United States|Delaware Smith Clinic Research, Delaware, Ohio, United States|Medical Frontiers, LLC, Franklin, Ohio, United States|Jeffrey J. Haggenjos, DO, Inc., New Lexington, Ohio, United States|Whole Family Medical Care LLC, Perrysburg, Ohio, United States|Office of Jocelyn F. Shimek, DO, Salem, Ohio, United States|Office of James Lassiter, Tiffin, Ohio, United States|Health Research Institute, LLC, Oklahoma City, Oklahoma, United States|Office of Siavash Nael, MD, Inc., Oklahoma City, Oklahoma, United States|Associates of Medicine/John D. Williams, MD, PLLC, Stillwater, Oklahoma, United States|Portland Rheumatology Clinic, LLC, Lake Oswego, Oregon, United States|Office of Joseph E. Yankee, DO, PC, Milwaukie, Oregon, United States|Pennsylvania Pain Specialists, PC, Allentown, Pennsylvania, United States|Ware Medical Associates, PC, Aston, Pennsylvania, United States|Altoona Center for Clinical Research, PC, Duncansville, Pennsylvania, United States|Kandra, Fierer, Kuskin Associates, Ltd., Harrisburg, Pennsylvania, United States|Onuorah Umeh, M.D. P.C, Philadelphia, Pennsylvania, United States|Founders Research Corporation, Philadelphia, Pennsylvania, United States|Progressive Pain Solutions, LLC, Wind Gap, Pennsylvania, United States|Hartwell Research Group, LLC, Anderson, South Carolina, United States|Low Country Rheumatology, PA, Charleston, South Carolina, United States|Pharmacorp Clinical Trials, Inc., Charleston, South Carolina, United States|Internal Medicine of Greer Research LLC, Greer, South Carolina, United States|Clinical Research Authority, LLC, Murrells Inlet, South Carolina, United States|Trident Institute of Medical Research, LLC, North Charleston, South Carolina, United States|Low Country Pain Center, LLC, Orangeburg, South Carolina, United States|Brown Clinic, PLLP, Watertown, South Dakota, United States|Chattanooga Medical Research, LLC, Chattanooga, Tennessee, United States|Comprehensive Pain Specialists, Hendersonville, Tennessee, United States|Corsicana Medical Research, PLLC, Corsicana, Texas, United States|DCT - Genesis Neighborhood Research, LLC, Dallas, Texas, United States|Southwest Urgent Care Center, El Paso, Texas, United States|Westbury Medical Clinic, Houston, Texas, United States|Accurate Clinical Research, Inc., Houston, Texas, United States|Medstar Clinical Research, Houston, Texas, United States|Texas Medical Research Associates, LLC, San Antonio, Texas, United States|Hillcrest Family Health Center, Division of Clinical Research, Waco, Texas, United States|Hillcrest Family Health Center, Waco, Texas, United States|Progressive Clinical Research, LLC, Bountiful, Utah, United States|Sentara Medical Group, NDC Medical Center, Norfolk, Virginia, United States|Washington Center for Pain Management PLLC, Edmonds, Washington, United States|Pain Care, PLLC, Huntington, West Virginia, United States URL: https://ClinicalTrials.gov/show/NCT01179191 Study 56: Title: JBT-101 in Systemic Lupus Erythematosus (SLE) Status: Recruiting Study Results: No Results Available Conditions: Systemic Lupus Erythematosus|SLE|Lupus Interventions: Drug: JBT-101|Drug: Placebo Locations: University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology, La Jolla, California, United States|UCLA Medical Center: Division of Rheumatology, Los Angeles, California, United States|University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center, San Francisco, California, United States|Yale University, New Haven, Connecticut, United States|Bronx-Lebanon Hospital Center: Division of Rheumatology, Bronx, New York, United States|Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases, Manhasset, New York, United States|New York University Langone Medical Center: Department of Medicine, Division of Rheumatology, New York, New York, United States|Columbia University Medical Center: Department of Medicine, Division of Rheumatology, New York, New York, United States|Duke University, Durham, North Carolina, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|Penn State MS Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States URL: https://ClinicalTrials.gov/show/NCT03093402 Study 57: Title: Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer Status: Recruiting Study Results: No Results Available Conditions: Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy (3D-CRT)|Drug: Docetaxel|Drug: Gemcitabine|Radiation: Intensity-Modulated Radiation Therapy (IMRT)|Drug: Pemetrexed Disodium|Radiation: Stereotactic Body Radiation Therapy (SBRT)|Drug: Erlotinib Hydrochloride|Drug: Pembrolizumab Locations: Arizona Breast Cancer Specialists-Gilbert, Gilbert, Arizona, United States|Arizona Center for Cancer Care-Peoria, Peoria, Arizona, United States|Mayo Clinic Hospital, Phoenix, Arizona, United States|Arizona Breast Cancer Specialists-Scottsdale, Scottsdale, Arizona, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States|The University of Arizona Medical Center-University Campus, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States|Saint Joseph Hospital - Orange, Orange, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Saint Helena Hospital, Saint Helena, California, United States|City of Hope South Pasadena, South Pasadena, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States|Poudre Valley Hospital, Fort Collins, Colorado, United States|Yale University, New Haven, Connecticut, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Tallahassee Memorial HealthCare, Tallahassee, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Cleveland Clinic-Weston, Weston, Florida, United States|Grady Health System, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States|Queen's Medical Center, Honolulu, Hawaii, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States|Northwestern University, Chicago, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Condell Memorial Hospital, Libertyville, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, United States|Parkview Regional Medical Center, Fort Wayne, Indiana, United States|Goshen Center for Cancer Care, Goshen, Indiana, United States|Community Cancer Center East, Indianapolis, Indiana, United States|Community Cancer Center South, Indianapolis, Indiana, United States|Franciscan Health Indianapolis, Indianapolis, Indiana, United States|Community Cancer Center North, Indianapolis, Indiana, United States|Franciscan Health Mooresville, Mooresville, Indiana, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|Via Christi Regional Medical Center, Wichita, Kansas, United States|The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States|Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Our Lady of the Lake Physicians Group - Medical Oncology, Baton Rouge, Louisiana, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Central Maryland Radiation Oncology in Howard County, Columbia, Maryland, United States|Tate Cancer Center, Glen Burnie, Maryland, United States|Peninsula Regional Medical Center, Salisbury, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|McLaren Cancer Institute-Clarkston, Clarkston, Michigan, United States|Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|McLaren Cancer Institute-Flint, Flint, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|McLaren Cancer Institute-Macomb, Mount Clemens, Michigan, United States|McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, United States|McLaren-Port Huron, Port Huron, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Saint Luke's Hospital of Duluth, Duluth, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Renown Regional Medical Center, Reno, Nevada, United States|Wentworth-Douglass Hospital, Dover, New Hampshire, United States|Virtua Memorial, Mount Holly, New Jersey, United States|Community Medical Center, Toms River, New Jersey, United States|Virtua Voorhees, Voorhees, New Jersey, United States|Lovelace Medical Center-Saint Joseph Square, Albuquerque, New Mexico, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Lovelace Radiation Oncology, Albuquerque, New Mexico, United States|Christus Saint Vincent Regional Cancer Center, Santa Fe, New Mexico, United States|Montefiore Medical Center-Einstein Campus, Bronx, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Mount Sinai Hospital, New York, New York, United States|University of Rochester, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Dickstein Cancer Treatment Center, White Plains, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|CarolinaEast Medical Center, New Bern, North Carolina, United States|NHRMC Radiation Oncology - Supply, Supply, North Carolina, United States|New Hanover Regional Medical Center/Zimmer Cancer Center, Wilmington, North Carolina, United States|NHRMC Radiation Oncology - 16th Street, Wilmington, North Carolina, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Roger Maris Cancer Center, Fargo, North Dakota, United States|Cleveland Clinic Akron General, Akron, Ohio, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Cleveland Clinic Cancer Center Mansfield, Mansfield, Ohio, United States|Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States|North Coast Cancer Care, Sandusky, Ohio, United States|University Pointe, West Chester, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Good Samaritan Hospital, Corvallis, Oregon, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States|UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania, United States|Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States|Paoli Memorial Hospital, Paoli, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Reading Hospital, West Reading, Pennsylvania, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States|Abington Memorial Hospital-Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, United States|Greenville Health System Cancer Institute-Faris, Greenville, South Carolina, United States|Greenville Health System Cancer Institute-Eastside, Greenville, South Carolina, United States|Self Regional Healthcare, Greenwood, South Carolina, United States|Greenville Health System Cancer Institute-Greer, Greer, South Carolina, United States|Gibbs Cancer Center-Pelham, Greer, South Carolina, United States|The Radiation Oncology Center-Hilton Head/Bluffton, Hilton Head Island, South Carolina, United States|Greenville Health System Cancer Institute-Seneca, Seneca, South Carolina, United States|Spartanburg Medical Center, Spartanburg, South Carolina, United States|Greenville Health System Cancer Institute-Spartanburg, Spartanburg, South Carolina, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States|Aurora Health Center-Fond du Lac, Fond Du Lac, Wisconsin, United States|Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States|Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin, United States|Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States|Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States|Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States|Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States|Aurora Cancer Care-Racine, Racine, Wisconsin, United States|Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States|Marshfield Clinic Stevens Point Center, Stevens Point, Wisconsin, United States|Aurora Medical Center in Summit, Summit, Wisconsin, United States|Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States|Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States|Aurora West Allis Medical Center, West Allis, Wisconsin, United States|London Regional Cancer Program, London, Ontario, Canada|Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, Canada|King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia URL: https://ClinicalTrials.gov/show/NCT03137771